MedPath

Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch

Phase 1
Completed
Conditions
Pruritus
Interventions
Registration Number
NCT02769910
Lead Sponsor
Hjalte Holm Andersen
Brief Summary

The purpose of this project is to investigate the effect of capsaicin-induced neurogenic inflammation with three different intensities on itch subsequently induced by histamine and cowhage. The hypothesis is that capsaicin-induced pre-established neurogenic inflammation significantly increases susceptibility to itch provocations with cowhage and histamine.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Healthy men and women
  • 18-60 years
  • Caucasian descent
  • Speak and understand English
Exclusion Criteria
  • Pregnancy or lactation
  • Drug addiction defined as any use of cannabis, opioids or other drugs
  • Previous or current neurologic, musculoskeletal or mental illnesses
  • Lack of ability to cooperate
  • Current use of medications that may affect the trial
  • Skin diseases
  • Consumption of alcohol or painkillers 24 hours before the study days and between these
  • Moles or tattoos in the area to be irradiated
  • Exposure of the irradiated area to UV radiation (e.g., sun) 48 hours before the study days and between these
  • Acute or chronic pain
  • Participation in other trials within 1 week of study entry (4 weeks in the case of pharmaceutical trials)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
CowhageCapsaicin 24 HoursCowhage is used to induce non-histaminergic itch on the volar forearm at the locations treated with Capsaicin 24 Hours, Capsaicin 1 Hours and Qutenza Demo Patch.
CowhageQutenza Demo PatchCowhage is used to induce non-histaminergic itch on the volar forearm at the locations treated with Capsaicin 24 Hours, Capsaicin 1 Hours and Qutenza Demo Patch.
HistamineCapsaicin 24 HoursHistamine is used to induce histaminergic itch on the volar forearm at the locations treated with Capsaicin 24 Hours, Capsaicin 1 Hour and Qutenza Demo Patch.
HistamineQutenza Demo PatchHistamine is used to induce histaminergic itch on the volar forearm at the locations treated with Capsaicin 24 Hours, Capsaicin 1 Hour and Qutenza Demo Patch.
CowhageCapsaicin 1 HourCowhage is used to induce non-histaminergic itch on the volar forearm at the locations treated with Capsaicin 24 Hours, Capsaicin 1 Hours and Qutenza Demo Patch.
HistamineCapsaicin 1 HourHistamine is used to induce histaminergic itch on the volar forearm at the locations treated with Capsaicin 24 Hours, Capsaicin 1 Hour and Qutenza Demo Patch.
Primary Outcome Measures
NameTimeMethod
Itch intensityAssessed continuously at 0-10 minutes following itch provocation

Rating of the perceived itch intensity on a visual analogue scale (VAS) App (Aalborg University) as displayed on a tablet computer with a sample rate of 1 Hz.

Secondary Outcome Measures
NameTimeMethod
Neurogenic inflammationAssessed 11 minutes after itch provocation

Neurogenic inflammation in the treated area is assessed using full-field laser perfusion imaging (FLPI)

Wheal sizeAssessed at 10 minutes following itch provocation

Histamine wheal size is assessed by measuring the longest diameter of the wheal with a ruler, followed by measuring the orthogonal diameter. The mean of these diameters will represent the wheal size in diameter, reported in mm.

Pain intensityAssessed continuously at 0-10 minutes following itch provocation

Rating of the perceived pain intensity on a visual analogue scale (VAS) App (Aalborg University) as displayed on a tablet computer with a sample rate of 1 Hz.

Changes in sensitivity to touch-evoked itchAssessed before, and at 12-15 minutes following itch provocation

Three von Frey filaments are applied to the test area before and after itch provocation. Subjects report three NRS scores ('0-10', 'No itch-Worst imaginable itch') for itch induced by von Frey stimulation. Change is calculated by subtracting baseline mean from post-provocation mean NRS scores.

Pain during capsaicin application24 hours after first application of capsaicin patch

Peak and average numerical rating scale (NRS) scores ('0-10, 'no pain-worst imaginable pain') are reported by subjects for each patch.

Trial Locations

Locations (1)

SMI

🇩🇰

Aalborg, NJ, Denmark

SMI
🇩🇰Aalborg, NJ, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.